CatalystFDA/Bio

ORIC (ORIC) Doubles Down On Prostate Cancer With Phase 3 Launch

ORIC launching Phase 3 prostate cancer trial signals major clinical catalyst.

What changed

ORIC launching Phase 3 prostate cancer trial signals major clinical catalyst.

Why it matters

ORIC launching Phase 3 prostate cancer trial signals major clinical catalyst. — impact context not separately stored; see What changed.

Sources